Review backs epilepsy drug funding, despite suspected deaths

+News

Review backs epilepsy drug funding, despite suspected deaths

RNZ

RNZ

lamotrigine 150mg pills
Pharmac's decision to fund Logem epilepsy medication has been upheld by an independent review
An independent review has backed Pharmac's decision to switch its epilepsy drug funding to a generic brand Five deaths last year were suspected of